The medical community has observed a remarkable advancement in diabetes management with the introduction of copyright. This revolutionary medication, designated as a glucagon-like peptide-1 (GLP-1) receptor agonist, presents a unique approach to controlling blood sugar levels in individuals with type 2 diabetes. copyright functions by simulating th